Clinical Trial Update: Transthyretin Amyloidosis Outcome Survey (THAOS)

View source ↗

Summary

Pfizer-sponsored THAOS transthyretin amyloidosis registry study has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Transthyretin Amyloidosis
• Transthyretin Amyloidosis

Snippet

Sponsor: Pfizer | Conditions: Transthyretin Gene Mutations, Transthyretin Amyloidosis | Status: COMPLETED | Results posted: 2024-11-22